Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs
15-Mar-2010 -
Trillium Therapeutics Inc. (TTI) announced that it has entered into two definitive license agreements with University Health Network (UHN) and The Hospital for Sick Children (SickKids) in Toronto, Ontario, granting Trillium exclusive worldwide rights to commercialize two immunology programs in ...
biotechnology
cancer stem cells
immunology
+5